Mechano-responsive structural coloration is especially valuable for information encryption due to the convenience of visualization and the simple authentication procedure. Here, a class of anisotropic photonic polydimethylsiloxane (PDMS) elastomers are...

Controllable stabilization of liquids on interfaces is emerging as a novel method to mediate surface properties. Here, the fast, stimuli‐responsive liquid release from dynamic polymer coatings is described to mediate surface slipperiness and optical performance. These polymer coatings consist of a slippery liquid‐locked rough surface and a liquid‐supplied bottom layer storing the liquid in embedded droplets. They are prepared by a simple one‐pot casting of a solution of cross‐linkable polymer and silicone oil in tetrahydrofuran. It is demonstrated that upon mechano‐, solvent‐, or thermo‐stimulation, the liquid stored in the bottom layer is released altering both surface slipperiness and optical properties of the coatings.

Accumulating recent evidence indicates that the human microbiome plays essential roles in pathophysiological states, including cancer. The tumor microbiome, an emerging concept that has not yet been clearly defined, has been proven to influence both cancer development and therapy through complex mechanisms. Small molecule metabolites produced by the tumor microbiome through unique biosynthetic pathways can easily diffuse into tissues and penetrate cell membranes through transporters or free diffusion, thus remodeling the signaling pathways of cancer and immune cells by interacting with biomacromolecules. Targeting tumor microbiome metabolism could offer a novel perspective for not only understanding cancer progression but also developing new strategies for the treatment of multiple cancer types. Here, we summarize recent advances regarding the role the tumor microbiome plays as a game changer in cancer biology. Specifically, the metabolites produced by the tumor microbiome and their potential effects on the cancer development therapy are discussed to understand the importance of the microbial metabolism in the tumor microenvironment. Finally, new anticancer therapeutic strategies that target tumor microbiome metabolism are reviewed and proposed to provide new insights in clinical applications.

No abstract